This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 2020 Jul-Aug;8(7):2412-2413.e2.

doi: 10.1016/j.jaip.2020.03.023. Epub 2020 Apr 5.

Mepolizumab for allergic bronchopulmonary aspergillosis: Report of 20 cases from the Belgian Severe Asthma Registry and review of the literature

Affiliations

Affiliations

¹ Department of Respiratory Medicine, CHU Sart-Tilman Liege, University of Liege, Liege, Belgium. Electronic address: fschleich@chuliege.be.
² Clinical Immunoallergology, CHU Brugmann, ULB, Brussels, Belgium.
³ Laboratory of Allergy & Mucosal Immunology and Cliniques Universitaires St-Luc, Université catholique de Louvain (UCL), Brussels, Belgium.
⁴ Department of Respiratory Medicine, CHU of Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium.
⁵ Department of Respiratory Medicine, centre hospitalier EpiCURA, Site de Baudour, Belgium.
⁶ Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
⁷ Department of Respiratory Medicine, CHU-Charleroi, A.Vésale Hospital, Charleroi, Belgium.
⁸ Department of Respiratory Medicine, Universitair Ziekenhuis, Brussels, Belgium.
⁹ Department of Respiratory Medicine, CHU Sart-Tilman Liege, University of Liege, Liege, Belgium.

PMID: 32268213
DOI: 10.1016/j.jaip.2020.03.023

Review

Mepolizumab for allergic bronchopulmonary aspergillosis: Report of 20 cases from the Belgian Severe Asthma Registry and review of the literature

Florence Schleich et al. J Allergy Clin Immunol Pract. 2020 Jul-Aug.

. 2020 Jul-Aug;8(7):2412-2413.e2.

doi: 10.1016/j.jaip.2020.03.023. Epub 2020 Apr 5.

Authors

Affiliations

¹ Department of Respiratory Medicine, CHU Sart-Tilman Liege, University of Liege, Liege, Belgium. Electronic address: fschleich@chuliege.be.
² Clinical Immunoallergology, CHU Brugmann, ULB, Brussels, Belgium.
³ Laboratory of Allergy & Mucosal Immunology and Cliniques Universitaires St-Luc, Université catholique de Louvain (UCL), Brussels, Belgium.
⁴ Department of Respiratory Medicine, CHU of Mont-Godinne, Université Catholique de Louvain, Yvoir, Belgium.
⁵ Department of Respiratory Medicine, centre hospitalier EpiCURA, Site de Baudour, Belgium.
⁶ Chest Department, Erasme University Hospital, Université Libre de Bruxelles, Brussels, Belgium.
⁷ Department of Respiratory Medicine, CHU-Charleroi, A.Vésale Hospital, Charleroi, Belgium.
⁸ Department of Respiratory Medicine, Universitair Ziekenhuis, Brussels, Belgium.
⁹ Department of Respiratory Medicine, CHU Sart-Tilman Liege, University of Liege, Liege, Belgium.

PMID: 32268213
DOI: 10.1016/j.jaip.2020.03.023

No abstract available

PubMed Disclaimer

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Medical
- MedlinePlus Consumer Health Information
- MedlinePlus Health Information